IISc, CELLINK ink deal to set up excellence centre for 3D bio-printing

3D Bio-printing

Bengaluru: CELLINK, a global leader in 3D bio-printing technology, and the Indian Institute of Science (IISc) are partnering to establish a Centre of Excellence (CoE) for an advanced  bio-printing technology in Bengaluru.

The CoE, the first of its kind in the subcontinent, will be housed in the Centre for BioSystems Science and Engineering (BSSE) at IISc, and will provide access to 3D bioprinting systems, enabling researchers to accelerate their work across critical applications, with the ultimate goal of improving health outcomes. An MoU was signed to formalise the collaboration on August 18.

The Centre will focus on advancing research on heart, bone, cartilage and cancer through the use of 3D bioprinting.

What is 3D bioprinting?

It is an application of additive manufacturing techniques to live cells, growth factors and/or biomaterials to fabricate biomedical parts, often with the aim to mimic natural tissue characteristics. 3D bioprinting covers a broad range of bioprinting techniques and biomaterials. Currently, bioprinting can be used to print tissue and organ models to help research drugs and potential treatments.

Also Read: IISc develops next-gen analog computing chipset for faster data processes

The new CoE will house several state-of-the-art 3D bioprinters from CELLINK and will serve as a hub for several research initiatives and training activities related to this emerging and exciting technology. Prof Govindan Rangarajan, Director, IISc, stated, “The CoE will contribute towards exploring new pathways in 3D bioprinting research and technology development. This would also align very well with the new initiative that we have launched to establish a post graduate medical school at IISc. I hope that the interdisciplinary collaboration through the CoE will create new medical technologies for affordable healthcare.”

IISc & CELLINK to hold joint workshop

IISc and CELLINK will work together to conduct workshops aimed at providing researchers within the institute, and elsewhere, the skills necessary to utilise 3D bioprinting in their work and reap the benefits of 3D cell culture. In addition to this, the two will undertake and advise on research projects across multiple applications spanning the fields of tissue engineering, drug discovery, material science and regenerative/personalised medicine. The Centre will have a keen focus on work around the heart, bone, cartilage and cancer.

Also Read: Scientists develop novel mechanism to inactivate SARS-CoV-2 virus

“We are excited to host this CoE in the Institute, which will help to initiate cutting-edge research in an emerging field of technology with immense potential to benefit human health,” said Prof Narendra Dixit, Chairperson of BSSE.

“It’s an honour to collaborate with one of the most prominent science institutes in India. India has long been at the forefront of scientific discovery, and with the exceptional talent and deep-rooted passion to translate research from the benchtop to the clinic, we are confident that this Centre of Excellence will make a lasting impact on the progress within research in the fields of heart, bone, cartilage and cancer. With IISc we have a tremendous partner and we look forward to creating the future of health together,” added Cecilia Edebo, CEO of CELLINK.

Previous articleBihar CM launches underground tunnel work of Patna metro rail project
Next articleIndia’s own 5G technology – 5Gi


Please enter your comment!
Please enter your name here